Novel Plasmid-Mediated tet (X5) Gene Conferring Resistance to Tigecycline, Eravacycline, and Omadacycline in a Clinical Acinetobacter baumannii Isolate

Author:

Wang Liyuan1,Liu Dejun2,Lv Yuan1,Cui Lanqing1,Li Yun1,Li Tianmeng1,Song Huangwei2,Hao Yuxin2,Shen Jianzhong2,Wang Yang2,Walsh Timothy R.23

Affiliation:

1. Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China

2. Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Veterinary Medicine, China Agricultural University, Beijing, China

3. Department of Medical Microbiology and Infectious Disease, Institute of Infection and Immunity, Cardiff, United Kingdom

Abstract

A novel, plasmid-mediated, high-level tigecycline resistance tet (X) gene variant, tet (X5), was detected in a clinical Acinetobacter baumannii isolate from China in 2017. Tet(X5) shows 84.5% and 90.5% amino acid identity to Tet(X3) and Tet(X4), respectively, with similar binding sites and a comparable affinity for tetracyclines. The tet (X5)-containing plasmid could only be transferred to A. baumannii via electrotransformation.

Funder

Medical Research Council grants DETER-XDRE-CHINA

National Natural Science Foundation of China

MOST | National Key Research and Development Program of China Stem Cell and Translational Research

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference13 articles.

1. Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis

2. Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia

3. Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans

4. European Committee on Antimicrobial Susceptibility Testing. 2019. Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0 2019. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_9.0_Breakpoint_Tables.pdf.

5. Clinical and Laboratory Standards Institute. 2019. Performance standards for antimicrobial susceptibility testing. CLSI M100-S29. Clinical and Laboratory Standards Institute, Wayne, PA.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3